Active Ingredient History
Norepinephrine, also known as noradrenaline, is a medication used to treat people with very low blood pressure. It is the typical medication used in sepsis if low blood pressure does not improve following intravenous fluids. It is the same molecule as the hormone and neurotransmitter norepinephrine. It is given by slow injection into a vein. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute Kidney Injury (Phase 4)
Acute Lung Injury (Phase 2)
Aged (Phase 4)
Alopecia (Phase 1)
Anesthesia (Phase 4)
Anesthesia, Epidural (Phase 4)
Anesthesia, General (Phase 4)
Anesthesia, Intravenous (Phase 4)
Anesthesia, Obstetrical (Early Phase 1)
Anesthesia, Spinal (Phase 4)
Arrhythmias, Cardiac (Phase 4)
Blood Pressure (Phase 4)
Brain Injuries, Traumatic (Phase 2)
Brain Ischemia (Phase 3)
Carcinoma, Hepatocellular (Phase 4)
Cardiac Output, Low (Phase 4)
Cardiovascular Diseases (Phase 1)
Cesarean Section (Phase 4)
Cognition Disorders (Phase 2/Phase 3)
Critical Illness (Phase 3)
Endotoxemia (Phase 4)
End Stage Liver Disease (Phase 4)
Fluid Therapy (Phase 3)
Free Tissue Flaps (Phase 4)
General Surgery (Phase 4)
Head and Neck Neoplasms (Phase 4)
Healthy Volunteers (Early Phase 1)
Heart Defects, Congenital (Phase 3)
Heart Disease Risk Factors (Phase 1)
Heart Diseases (Phase 3)
Heart Failure (Phase 1)
Hemodynamics (Phase 4)
Hepatorenal Syndrome (Phase 3)
Hypertension (Phase 1/Phase 2)
Hypertension, Pulmonary (Phase 1)
Hypotension (Phase 4)
Infant (Phase 3)
Infections (Phase 2/Phase 3)
Inflammation (Phase 1)
Insulin Resistance (Phase 1)
Ischemic Stroke (Phase 2)
Kidney Diseases (Phase 2/Phase 3)
Kidney Transplantation (Phase 2/Phase 3)
Liver Cirrhosis (Phase 4)
Liver Transplantation (Phase 4)
Methylphenidate (Phase 4)
Microcirculation (Phase 4)
Mouth Neoplasms (Phase 4)
Obesity (Early Phase 1)
Pharmacogenetics (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 1)
Radiodermatitis (Phase 1/Phase 2)
Respiration, Artificial (Phase 4)
Respiratory Insufficiency (Phase 3)
Sepsis (Phase 4)
Shock (Phase 4)
Shock, Cardiogenic (Phase 4)
Shock, Septic (Phase 4)
Subarachnoid Hemorrhage (Phase 3)
Systemic Inflammatory Response Syndrome (Phase 4)
Tachycardia (Phase 4)
Vasoconstriction (Phase 1)
Vasodilation (Early Phase 1)
Vasoplegia (Phase 3)
Vasopressins (Phase 4)
Ventricular Dysfunction, Right (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue